An ultrastructural and immunohistochemical study of pigmented dermatofibrosarcoma protuberans (Bednar tumor)

European Journal of Dermatology

Volumn 9, Issue 5, 1999, Pages 366-369

  Kagoura, Masayori ^a   Toyoda, Masahiko ^a   Nagahori, Hidefumi ^a   Makino, Teruhiko ^a   Morohashi, Masaaki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

CD 34; Factor X IIIa; Immunohistochemistry; Pigmented dermatofibrosarcoma protuberans; Ultrastructural study

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CELL ULTRASTRUCTURE; CLINICAL FEATURE; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; SURGICAL TECHNIQUE; TUMOR BIOPSY;

EID: 0032791108     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1. Fletcher CDM, Evans BJ, Macartney JC, Smith N, Wilson JE, McKee PH. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathol 1985; 9: 921-38.
2. 2. Heenan PJ. Tumors of the fibrous tissue involving the skin. In: Elder D, Elenitsas R, Jaworsky C, Johnson B Jr., eds. Lever's histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven Publications, 1997: 847-87.
3. 3. Alguacil-Garcia A, Unni KK, Goellner JR. Histogenesis of dermatofibrosarcoma protuberans: an ultrastructural study. Am J Clin Pathol 1978; 69: 427-34.
4. 4. Lautier R, Wolff HH, Jones RE. An immunohistochemical study of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Am J Dermatopathol 1990; 12: 25-30.
5. 5. Ma CK, Sorb RJ, Gown AM. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosorcoma protuberans. Am J Clin Pathol 1992; 97: 478-83.
6. 6. Bednar B. Storiform neurofibromas of the skin, pigmented or non-pigmented. Cancer 1957; 10: 368-76.
7. 7. Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): a pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 1985; 9: 630-9.
8. 8. Löpez JI, Elizalde JM, Fernandez-Larrinoa A. Pigment dermatofibrosarcoma protuberans (Bednar tumour). Dermatol 1992; 184: 281-2.
9. 9. Nakamura T, Ogata H, Katsuyama T. Pigmented dermatofibrosarcoma protuberans: report of two cases as a variant of dermatofibrosarcoma protuberans with partial neural differentiation. Am J Dermatopathol 1987; 9: 18-25.
10. 10. Fletcher CDM, Theaker JM, Flanagan A, Krausz T. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study. Histopathol 1988; 13: 631-43.
11. 11. Ding J, Hashimoto H, Sugimoto T, Tsuneyoshi M, Enjoji M. Bednar tumor (pigmented dermatofibrosarcoma protuberans). An analysis of six cases. Acta Pathol Jpn 1990; 40: 744-54.
12. 12. Onoda N, Tsutsumi Y, Kakudo K, Ozawa A, Niizuma K, Ohkid M, Osamura RY. Pigmented dermatofibrosarcoma protuberans (Bednar tumor): an autopsy case with systemic metastasis. Acta Pathol Jpn 1990; 40: 935-40.
13. 13. Shikata N, Kurokawa I, Andachi H, Tsubura A. Expression of androgen receptors in skin appendage tumors: an immunohistochemical study. J Cutan Pathol 1995; 22: 149-53.
14. 14. Hameed A, Hruban RH, Gage W, Pettis G, Fox WM. Immunohistochemical expression of CD 68 antigen in human peripheral bood T cells. Hum Pathol 1994; 25: 872-6.
15. 15. Akasaka T, Ohyama N, Kon S. A case of pigmented dermatofibrosarcoma protuberans (Bednar tumor). J Dermatol 1997; 24: 390-4.
16. 16. Kobayashi T, Hasegawa Y, Konohana A, Nakamura N. A case of Bednar tumor. Immunohistochemical positivity for CD 34. Dermatol 1997; 195: 57-9.
17. 17. Mochizuki Y, Narisawa Y, Kohda H. A case of Bednar tumor recurring after 23 years. J Dermatol 1996; 23: 614-8.